Search

everythinglearnresearchcommunity

for

Search:↓

Activated and non-activated PRP are equally safe and effective for treating alopecia areata.

Over a third of women thought to have non-classical congenital adrenal hyperplasia didn't have it confirmed by genetic tests.

Bimatoprost and clobetasol are both effective for scalp hair loss, but bimatoprost works faster, has fewer side effects, and grows more colored hair.

Women with Polycystic Ovary Syndrome are more likely to have Non-Alcoholic Fatty Pancreas Disease, which is associated with older age, metabolic syndrome, insulin resistance, and high male hormone levels.

The document concludes that skin aging in women can be caused by UV exposure and hormonal changes, and treatments like hormone replacement therapy and various skin therapies can help.

A woman with Parkinson's disease experienced hair loss from the Parkinson's medication pramipexole, which improved after stopping the drug.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

Apremilast shows promise for several skin conditions but needs more research.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

Hair problems are common and distressing for women, but increasing knowledge of treatments offers hope.

Scalp areas that look normal in people with hair loss may still show signs of disease under a microscope.

Afro-textured hair is more fragile and prone to certain scalp conditions, requiring careful treatment and more research for effective management.

Accurate diagnosis is crucial for effective treatment of hair loss.

The algorithm accurately identified alopecia in women of childbearing age using claims data.

Women with hair loss have weaker hair that breaks more easily.

Hair loss in elderly women is often caused by various factors, including hormonal changes after menopause.

A systematic approach is crucial for managing hair loss in women.

Older women face various skin issues like dryness and thinning, and treatments are available but can have side effects; proper skin care and legal health decisions are important.

Blood tests are needed to confirm high male hormone levels in women with PCOS, as physical signs alone are not reliable.

The document concluded that cyproterone acetate and minoxidil are effective for female hair loss, and a supportive doctor-patient relationship is important.

Microtrauma techniques like microneedling and PRP can help regrow hair in non-scarring alopecia.

Brownish halos around axillary hair can help diagnose frontal fibrosing alopecia.

The document concludes that ongoing medical therapy is crucial for preventing hair loss, and surgical options can restore hair, with future treatments for hair loss being promising.

Women with early-onset baldness should be checked for early bone loss, but bone density doesn't change with baldness severity.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

No current patient-reported outcome measure fully meets FDA requirements for alopecia treatments.

Women with PCOS often experience anxiety, depression, and a lower quality of life.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

Women under 55 with hair loss (AGA) may have a higher risk of heart disease (CAD).